| 1 |
33347861 | The metabolic importance of the overlooked asparaginase II pathway. | 2022 May 1 |
1 |
| 2 |
35592619 | Primary hyperoxaluria type 1: pathophysiology and genetics. | 2022 May |
2 |
| 3 |
35601556 | Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening. | 2022 |
2 |
| 4 |
34433051 | Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria. | 2021 Aug 24 |
1 |
| 5 |
32792227 | The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization. | 2020 Sep - Oct |
3 |
| 6 |
30676254 | Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1. | 2019 Apr |
1 |
| 7 |
29110180 | Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6. | 2018 Mar |
1 |
| 8 |
29243158 | Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. | 2018 May |
2 |
| 9 |
29244539 | Genotype-phenotype variability of retinal manifestation in primary hyperoxaluria type 1. | 2018 Apr |
1 |
| 10 |
28916765 | Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis. | 2017 Sep 15 |
3 |
| 11 |
28969594 | Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations. | 2017 Oct 2 |
1 |
| 12 |
26689264 | Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I. | 2016 Apr |
1 |
| 13 |
26854734 | Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. | 2016 Jun |
3 |
| 14 |
27179589 | Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism. | 2016 Sep |
7 |
| 15 |
27670739 | High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1. | 2016 Sep 27 |
1 |
| 16 |
25620715 | Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. | 2015 Sep |
3 |
| 17 |
26252291 | Left Lateral Sectionectomy of the Native Liver and Combined Living-Related Liver-Kidney Transplantation for Primary Hyperoxaluria Type 1. | 2015 Aug |
1 |
| 18 |
25237136 | Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. | 2014 Oct 7 |
2 |
| 19 |
25461797 | The lower limits for protein stability and foldability in primary hyperoxaluria type I. | 2014 Dec |
1 |
| 20 |
22018727 | Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I. | 2012 Jan |
4 |
| 21 |
22446032 | Primary hyperoxalurias: disorders of glyoxylate detoxification. | 2012 Sep |
1 |
| 22 |
21558762 | Studies on a unique organelle localization of a liver enzyme, serine:pyruvate (or alanine:glyoxylate) aminotransferase. | 2011 |
1 |
| 23 |
20056990 | Encapsulating peritoneal sclerosis in a patient with primary hyperoxaluria type 1: a case report. | 2010 Jan-Feb |
1 |
| 24 |
19155213 | Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation. | 2009 Mar 27 |
1 |
| 25 |
19479957 | Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. | 2009 Jun |
5 |
| 26 |
19545238 | Recombinant production of eight human cytosolic aminotransferases and assessment of their potential involvement in glyoxylate metabolism. | 2009 Aug 13 |
4 |
| 27 |
19887726 | Assay of alanine:glyoxylate aminotransferase in human liver by its serine: glyoxylate aminotransferase activity. | 2009 Oct |
3 |
| 28 |
18289107 | Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli. | 2008 |
1 |
| 29 |
16309382 | Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells. | 2006 Mar 1 |
2 |
| 30 |
16922352 | [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene]. | 2006 Jul 29 |
3 |
| 31 |
15580638 | Maternal isodisomy of the telomeric end of chromosome 2 is responsible for a case of primary hyperoxaluria type 1. | 2005 Jan 1 |
1 |
| 32 |
15240345 | Glycolate and glyoxylate metabolism in HepG2 cells. | 2004 Nov |
1 |
| 33 |
15464418 | Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis. | 2004 Sep-Oct |
2 |
| 34 |
11699734 | Detection of AGXT bgene mutations by denaturing high-performance liquid chromatography for diagnosis of hyperoxaluria type 1. | 2001 Jun |
2 |
| 35 |
11330044 | Primary hyperoxaluria type 1 in Japan. | 2000 |
4 |
| 36 |
8747487 | Aminooxy acetic acid: a selective inhibitor of alanine:glyoxylate aminotransferase and its use in the diagnosis of primary hyperoxaluria type I. | 1995 Dec 29 |
1 |
| 37 |
8507692 | Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase. | 1993 |
1 |
| 38 |
20301460 | Primary Hyperoxaluria Type 1 | 1993 |
2 |
| 39 |
6703688 | The effect of vitamin B6 deficiency on alanine: glyoxylate aminotransferase isoenzymes in rat liver. | 1984 Feb 15 |
1 |